The Ipsen Investment Case

Clear focus on three therapeutic areas A future built on Specialty Care Nadine Living with fibrodysplasia ossificans progressiva Berlin, Germany IPSEN Innovation for patient care Our vision To be a leading global mid-sized biopharmaceutical company with a focus on transformative medicines in Oncology, Rare Disease and Neuroscience DIDA Oncology Rare Disease Neuroscience Strengthening the position Expanding the scope Consumer Healthcare: exclusive negotiations with Mayoly Spindler Excelling and accelerating 3

View entire presentation